As an Air India Express pilot in his 30s died of cardiac arrest shortly after landing his flight from Srinagar to Delhi, the focus has shifted to the increased incidence of sudden cardiac arrest in ...

An Air India Express pilot, Armaan, passed away at Delhi Airport. He suffered a cardiac arrest after safely operating a flight from Srinagar. Armaan vomited in the lavatory and collapsed.

Cardiology is a medical specialty that is concerned with the structure and function of the heart and vasculature, and the diagnosis and treatment of patients with cardiovascular diseases ...

This little pill — taken by adults and children alike — might just be a prescription for heart disease. Speaking to The Post, the veteran heart doctor tackled a drug that is commonly ...

Dr. Evan Levine tackles a drug that is often prescribed to help children perform better -- a phenomenon he calls "borderline child abuse." ...

BHOPAL: Craving for mouth-watering chicken delicacies landed "fake cardiologist" N John Camm aka Narendra Yadav in Madhya Pradesh police's custody, it has emerged. Tracking his cell-phone location ...

Bhopal, Apr 8: The cardiologist of a hospital in Madhya Pradesh’s Damoh district, allegedly linked to the death of seven heart patients, has reportedly forged his medical degree certificate ...

Of the 342 cardiology clinics that have been acquired in the past decade, more than 94% occurred from 2021 to 2023. Cardiology is rather newto theprivate equity space compared with specialties ...

Sudden cardiac arrest symptoms include sudden loss of consciousness, responsiveness, breathing, and pulse. This may be preceded by dizziness, shortness of breath, a racing heartbeat, or abnormal ...

Police are investigating his medical qualifications. They are verifying his claim of performing 15,000 cardiac operations. Authorities are checking his MBBS degree and past work at hospitals.

New research finds a link between using antidepressants and a higher risk of sudden cardiac death. Some antidepressant users have an up to five times greater risk of sudden cardiac death.

Results of the phase 2b PURSUIT study, which evaluated AZD0780 (AstraZeneca), an oral small molecule PCSK9 inhibitor, were presented at the American College of Cardiology Scientific Session.